# Clinical Experience of Thalidomide in Thalassemic Patients

> **NCT05132270** · PHASE2,PHASE3 · COMPLETED · sponsor: **Children's Hospital Karachi** · enrollment: 135 (actual)

## Conditions studied

- Thalassemia, Beta

## Interventions

- **DRUG:** hydroxyurea and thalidomide

## Key facts

- **NCT ID:** NCT05132270
- **Lead sponsor:** Children's Hospital Karachi
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-01-31
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2021-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05132270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05132270, "Clinical Experience of Thalidomide in Thalassemic Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05132270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*